Definitive Contract 75D30121C10164
Award Date
1/1/21
Potential Completion Date
12/31/30
Potential Value
$16M
Federal Agency
CDC Pittsburgh
Awardee
Case Western Reserve University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Uganda
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
22
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Denver Health and Hospital Authority, doing business as Denver Health, to provide tuberculosis trials and consortium services over a 10-year period. The contract has a ceiling value of $3,780,225.28 and was awarded on January 1, 2021, with an ultimate completion date of December 31, 2030. The contract requires Denver Health to participate in clinical research studies on the treatment,...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County, for tuberculosis trials and consortium services. The $10,667,136.30 contract has an ultimate completion date of December 31, 2030. It does not have a set-aside designation, indicating it was competed on a full and open basis. The contract will support clinical trials and research on the treatment, diagnosis, and prevention of...
This is a $985,616.22 definitive contract awarded to Case Western Reserve University by the Department of Health and Human Services Centers for Disease Control and Prevention for the Tuberculosis Trials Consortium (TBTC) project. The contract is a cost-no-fee arrangement with a completion date of March 17, 2021. As a private university, Case Western Reserve University provides a range of research and development services to federal agencies, including work in areas such as biomedical research,...
This federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to Weill Medical College of Cornell University, doing business as Joan & Sanford I Weill Medical College of Cornell University, for tuberculosis trials and consortium services. The 10-year, $5,917,206.24 contract is a definitive, cost-no-fee contract that does not have a set-aside designation. The contract supports clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis,...
The Centers for Disease Control and Prevention (CDC) awarded a $9,856,205.74 definitive contract to The Medical University of South Carolina (MUSC) for tuberculosis clinical trials and research support. The contract runs from January 1, 2021 to December 31, 2030 and does not have a set-aside designation. The University of Cape Town in South Africa is a major subcontractor, providing pharmacokinetics research support for the trials. This contract is part of the CDC's Tuberculosis Trials...
Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...
The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...
This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Siris Pharmaceutical Services LLC, a woman-owned small business, to provide tuberculosis (TB) clinical trials management support. The contract has a ceiling value of $2,395,614.70 and is a time and materials contract with a period of performance ending on September 10, 2026. The contract is designated as a total small business set-aside. This contract supports the CDC's efforts to advance TB research...